JP2012021033A5 - - Google Patents

Download PDF

Info

Publication number
JP2012021033A5
JP2012021033A5 JP2011236442A JP2011236442A JP2012021033A5 JP 2012021033 A5 JP2012021033 A5 JP 2012021033A5 JP 2011236442 A JP2011236442 A JP 2011236442A JP 2011236442 A JP2011236442 A JP 2011236442A JP 2012021033 A5 JP2012021033 A5 JP 2012021033A5
Authority
JP
Japan
Prior art keywords
cells
container
composition
cross
infusion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011236442A
Other languages
English (en)
Japanese (ja)
Other versions
JP5649551B2 (ja
JP2012021033A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2012021033A publication Critical patent/JP2012021033A/ja
Publication of JP2012021033A5 publication Critical patent/JP2012021033A5/ja
Application granted granted Critical
Publication of JP5649551B2 publication Critical patent/JP5649551B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2011236442A 2004-03-01 2011-10-27 細胞治療処方方法および組成物 Expired - Lifetime JP5649551B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54903204P 2004-03-01 2004-03-01
US60/549,032 2004-03-01

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2007501882A Division JP5144250B2 (ja) 2004-03-01 2005-03-01 細胞治療処方方法および組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014015195A Division JP2014077018A (ja) 2004-03-01 2014-01-30 細胞治療処方方法および組成物

Publications (3)

Publication Number Publication Date
JP2012021033A JP2012021033A (ja) 2012-02-02
JP2012021033A5 true JP2012021033A5 (enExample) 2013-02-28
JP5649551B2 JP5649551B2 (ja) 2015-01-07

Family

ID=34919427

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2007501882A Expired - Lifetime JP5144250B2 (ja) 2004-03-01 2005-03-01 細胞治療処方方法および組成物
JP2011236442A Expired - Lifetime JP5649551B2 (ja) 2004-03-01 2011-10-27 細胞治療処方方法および組成物
JP2014015195A Withdrawn JP2014077018A (ja) 2004-03-01 2014-01-30 細胞治療処方方法および組成物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2007501882A Expired - Lifetime JP5144250B2 (ja) 2004-03-01 2005-03-01 細胞治療処方方法および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014015195A Withdrawn JP2014077018A (ja) 2004-03-01 2014-01-30 細胞治療処方方法および組成物

Country Status (10)

Country Link
EP (2) EP1749090B1 (enExample)
JP (3) JP5144250B2 (enExample)
CA (1) CA2530514C (enExample)
DK (1) DK1749090T3 (enExample)
ES (1) ES2635868T3 (enExample)
HU (1) HUE035726T2 (enExample)
IL (3) IL173405A (enExample)
PL (1) PL1749090T3 (enExample)
PT (1) PT1749090T (enExample)
WO (1) WO2005084276A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110142887A1 (en) * 2009-12-15 2011-06-16 Immunovative Therapies Ltd. Methods and compositions for liquidation of tumors
US7592431B2 (en) * 2004-02-26 2009-09-22 Immunovative Therapies, Ltd. Biodegradable T-cell Activation device
SI2573166T1 (sl) 2004-02-26 2016-09-30 Immunovative Therapies, Ltd. Metode za pripravo T-celic za celično terapijo
PH12013502252B1 (en) 2011-05-03 2018-09-21 Immunovative Therapies Ltd Induction of il-12 using immunotherapy
KR102202460B1 (ko) 2011-05-03 2021-01-14 이뮤노베이티브 테라피스, 엘티디. 생세포를 포함하는 생물학적 약물을 처리하기 위한 방법
WO2015105999A1 (en) * 2014-01-08 2015-07-16 Immunovative Therapies, Ltd. Treatment of human immunodeficiency virus/acquired immunodeficiency syndrome

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766920A (en) 1982-08-11 1998-06-16 Cellcor, Inc. Ex vivo activation of immune cells
WO1988000970A2 (en) 1986-08-08 1988-02-11 Regents Of The University Of Minnesota Method of culturing leukocytes
US6905680B2 (en) * 1988-11-23 2005-06-14 Genetics Institute, Inc. Methods of treating HIV infected subjects
US6534055B1 (en) * 1988-11-23 2003-03-18 Genetics Institute, Inc. Methods for selectively stimulating proliferation of T cells
US5126132A (en) 1989-08-21 1992-06-30 The United States Of America As Represented By The Department Of Health And Human Services Tumor infiltrating lymphocytes as a treatment modality for human cancer
US5728388A (en) 1989-10-03 1998-03-17 Terman; David S. Method of cancer treatment
CA2065658A1 (en) * 1991-04-19 1992-10-20 Tse-Wen Chang Conjugates of liposomes or microbeads and antibodies specific for t lymphocytes and their use in vivo immune modulators
WO1994012196A1 (en) * 1992-11-25 1994-06-09 Tanox Biosystems, Inc. Conjugates and constructs including anti-cd28 and anti-cd3 binding molecules
WO1994029436A1 (en) * 1993-06-04 1994-12-22 The United States Of America Represented By The Secretary Of The Navy Methods for selectively stimulating proliferation of t cells
EP0726941B1 (en) 1993-08-06 2002-04-03 Epimmune Inc. Methods for (ex vivo) therapy using peptide-loaded antigen presenting cells for the activation of ctl
CA2191586A1 (en) * 1994-06-03 1995-12-14 Carl H. June Methods for selectively stimulating proliferation of t cells
US5827642A (en) 1994-08-31 1998-10-27 Fred Hutchinson Cancer Research Center Rapid expansion method ("REM") for in vitro propagation of T lymphocytes
EP0814838B1 (en) 1995-03-08 2003-05-14 The Scripps Research Institute Antigen presenting system and activation of t-cells
JP2002515756A (ja) 1997-01-31 2002-05-28 ヘモソル インク. 選択されたリンパ球の生産方法
US20030119185A1 (en) * 2000-02-24 2003-06-26 Xcyte Therapies, Inc. Activation and expansion of cells
US20040258661A1 (en) * 2001-10-31 2004-12-23 Daniel Fowler Generation of use of tc1 and tc2 cells
AU2003202908A1 (en) * 2002-01-03 2003-07-24 The Trustees Of The University Of Pennsylvania Activation and expansion of t-cells using an engineered multivalent signaling platform
US7435592B2 (en) * 2003-05-13 2008-10-14 Immunovative Therapies, Ltd. Compositions for allogeneic cell therapy
SI2573166T1 (sl) * 2004-02-26 2016-09-30 Immunovative Therapies, Ltd. Metode za pripravo T-celic za celično terapijo

Similar Documents

Publication Publication Date Title
JP2018029594A5 (enExample)
WO2011158240A3 (en) Biodegradable sheet and an array of separable pouches for liquids
JP2016526086A5 (enExample)
JP2013538922A5 (enExample)
JP2010194332A5 (enExample)
RU2018122666A (ru) Система подачи аэрозоля с электрическим питанием
RU2580315C3 (ru) Композиции для респираторной доставки активных веществ и связанные с ними способы и системы
IL218085A0 (en) Use of antibodies or other specific binding molecules directed to dc-asgpr, in the preparation of medicaments for delivering antigens to antigen-presenting cells
EP2696412A4 (en) NEGATIVELY ACTIVE ELECTRODE MATERIAL FOR A LITHIUM CERTAIN BATTERY AND METHOD FOR THE PRODUCTION THEREOF
MX352433B (es) Material tipo pelicula,fibra, tela tejida y no tejida con adsorbencia.
JP2014509532A5 (enExample)
CN105682624B8 (zh) 吸收复合物、采用该吸收复合物的吸收制品以及制造该吸收复合物的方法、系统
Chen Blowup criterion for viscous, compressible micropolar fluids with vacuum
JP2012192206A5 (enExample)
EP2796524A4 (en) RESIN COMPOSITION FOR A SEALANT, LAMINATED FOIL AND PACKAGING BAG
JP2013535428A5 (enExample)
JP2015531241A5 (enExample)
RU2014101927A (ru) Фильтровальный материал, включающий полилактидные волокна
WO2013182497A3 (en) Low density composite materials, their production and use
RU2018141598A (ru) Картридж, содержащий соединительный элемент, для применения в системе, генерирующей аэрозоль
EP2565161A4 (en) NOVEL LITHIUM TITANATE, PRODUCTION METHOD THEREFOR, ACTIVE ELECTRODE MATERIAL CONTAINING THE SAME, AND ELECTRIC BATTERY USING SAID ACTIVE ELECTRODE MATERIAL
MX2017002267A (es) Bolsa flexible con bandas de soporte con memoria y metodos para producirla y usarla.
JP2015526316A5 (enExample)
JP6844260B2 (ja) 培養容器、及び培養容器の製造方法
JP2011219159A5 (enExample)